Gujarat Terce Laboratories Intrinsic Value
Gujarat Terce Laboratories (GUJTERC) median intrinsic value is ₹37.70 from 8 valuation models (range ₹16–₹67), vs current price ₹33.35 — +13.0% upside (Trading Below Median Value), margin of safety 11.5%. Analyse GUJTERC shareholding pattern to track promoter, FII and institutional holdings.
GUJTERC Valuation Methods Summary — DCF, Graham Number & P/E
Gujarat Terce Laboratories intrinsic value across 8 models vs current price ₹33.35 — upside/downside and value range per method. Read Gujarat Terce Laboratories dividend policy for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹53.68 | ₹42.94 - ₹64.42 | +61.0% | EPS: ₹2.44, Sector P/E: 22x |
| Book Value Method | asset | ₹25.00 | ₹22.50 - ₹27.50 | -25.0% | Book Value/Share: ₹12.50, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹66.70 | ₹60.03 - ₹73.37 | +100.0% | Revenue/Share: ₹50.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹50.00 | ₹45.00 - ₹55.00 | +49.9% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹34.81 | ₹27.85 - ₹41.77 | +4.4% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹15.62 | ₹14.06 - ₹17.18 | -53.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹37.70 | ₹33.93 - ₹41.47 | +13.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹25.00 | ₹22.50 - ₹27.50 | -25.0% | EPS: ₹2.44, BVPS: ₹12.50 |
GUJTERC Intrinsic Value vs Market Price — All Valuation Models
Gujarat Terce Laboratories fair value range ₹16–₹67 vs current market price ₹33.35 across 8 valuation models. For current market price and key ratios, visit Gujarat Terce Laboratories share price chart.
GUJTERC Intrinsic Value Analysis — Undervalued or Overvalued?
Gujarat Terce Laboratories median intrinsic value ₹37.70, current price ₹33.35 — Trading Below Median Value by 13.0%, margin of safety 11.5%.
What is the intrinsic value of GUJTERC?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Gujarat Terce Laboratories (GUJTERC) is ₹37.70 (median value). With the current market price of ₹33.35, this represents a +13.0% variance from our estimated fair value.
The valuation range spans from ₹15.62 to ₹66.70, indicating ₹15.62 - ₹66.70.
Is GUJTERC undervalued or overvalued?
Based on our multi-method analysis, Gujarat Terce Laboratories (GUJTERC) appears to be trading below median value by approximately 13.0%.
GUJTERC Financial Health — Key Ratios vs Industry Benchmarks
Gujarat Terce Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.60x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
GUJTERC Cash Flow Quality — Operating & Free Cash Flow
Gujarat Terce Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |